
Matthew James Pianko MD (He/Him)
Hematologic Oncology
Clinical Associate Professor - University of Michigan
Join to View Full Profile
1500 E. Medical Center Dr.C342 Med Inn Bldg, SPC 5848Ann Arbor, MI 48109
Phone+1 734-647-0118
Dr. Pianko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matthew Pianko is a hematologist specializing in hematologic oncology, based in Ann Arbor, MI. He completed his medical education at Stanford University and received further training from Memorial Sloan Kettering Cancer Center and New York Presbyterian Hospital. He has been affiliated with the University of Michigan Medical School since 2018, currently holding the position of Clinical Associate Professor. His expertise includes immunotherapy, hematologic oncology, and multiple myeloma. Dr. Pianko has contributed to several peer-reviewed publications and participated in clinical trials related to his field. Throughout his career, he has been recognized with honors such as the Mortimer P. Lacher Fellowship and the Humanism and Excellence in Teaching Award. He currently serves at Michigan as co-chair of the Hematologic malignancies clinical research team and co-chair of the Big Ten Cancer Research Consortium Clinical Trials Working Group.
Clinical Expertise
- Hematology, Hematologic oncology, Medical oncology, Immunotherapy
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
Stanford University School of MedicineClass of 2011
Certifications & Licensure
MI State Medical License 2018 - 2028
NY State Medical License 2012 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Mortimer P. Lacher Fellow The Lymphoma Foundation of MSKCC, 2017-2018
- Humanism and Excellence in Teaching Award Arnold P. Gold Foundation, 2013
Clinical Trials
- S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration Start of enrollment: 2019 Aug 13
Publications & Presentations
PubMed
- Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma.Matthew J Pianko, Niodita Gupta-Werner, Bruno Emond, Patrick Lefebvre, Marie-Hélène Lafeuille
Future Science OA. 2025-12-01 - Current experiences with teclistamab in patients with multiple myeloma and renal impairment.Meletios A Dimopoulos, Yael C Cohen, Aurore Perrot, Matthew J Pianko, Edward A Faber
Expert Review of Hematology. 2025-10-02 - Refining renal response assessment in monoclonal immunoglobulin deposition disease: Challenges, limitations and need for consensus.Sabine Karam, Matthew J Pianko, Hani Hassoun
Leukemia. 2025-09-01
Press Mentions
COVID-19 Update: Casinos Get Reopening Rules but No Start Date, Hospitality Group Publishes Guidelines, and MoreJune 9th, 2020
Professional Memberships
- Member
- Member
- Member
- Society for Immunotherapy of CancerMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









